Lisinopril
Treatment for Chronic Kidney Disease Due To Diabetes Mellitus Type 1
Typical Dosage: 5-40mg daily
Effectiveness
85%
Safety Score
70%
Clinical Trials
300
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
5-40mg daily
Time to Effect
Weeks for BP control, months for albuminuria reduction, years for kidney protection
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
15(Treat 15 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$385
Cost per Remission
$3,333
Lisinopril Outcomes
for Chronic Kidney Disease Due To Diabetes Mellitus Type 1
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+65%
Remission Rate
+7.5%
Common Side Effects
Cough
+10%
Hyperkalemia
+3%
Hypotension
+3%
Angioedema
+0.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov